Request for Covid-19 Impact Assessment of this Report
The United States Psoriatic Arthritis Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Psoriatic Arthritis Drugs market, reaching US$ million by the year 2028. As for the Europe Psoriatic Arthritis Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Psoriatic Arthritis Drugs players cover Abbvie, Janssen, Amgen, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriatic Arthritis Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Mild Psoriatic Arthritis
Moderate Psoriatic Arthritis
Severe Psoriatic Arthritis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbvie
Janssen
Amgen
Pfizer
Eli-Lilly
Celgene
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Psoriatic Arthritis Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Psoriatic Arthritis Drugs by Country/Region, 2017, 2022 & 2028
2.2 Psoriatic Arthritis Drugs Segment by Type
2.2.1 TNF Inhibitors
2.2.2 PDE4 Inhibitors
2.2.3 Interleukin Blockers
2.2.4 Other
2.3 Psoriatic Arthritis Drugs Sales by Type
2.3.1 Global Psoriatic Arthritis Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Psoriatic Arthritis Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Psoriatic Arthritis Drugs Sale Price by Type (2017-2022)
2.4 Psoriatic Arthritis Drugs Segment by Application
2.4.1 Mild Psoriatic Arthritis
2.4.2 Moderate Psoriatic Arthritis
2.4.3 Severe Psoriatic Arthritis
2.5 Psoriatic Arthritis Drugs Sales by Application
2.5.1 Global Psoriatic Arthritis Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Psoriatic Arthritis Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Psoriatic Arthritis Drugs Sale Price by Application (2017-2022)
3 Global Psoriatic Arthritis Drugs by Company
3.1 Global Psoriatic Arthritis Drugs Breakdown Data by Company
3.1.1 Global Psoriatic Arthritis Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Psoriatic Arthritis Drugs Sales Market Share by Company (2020-2022)
3.2 Global Psoriatic Arthritis Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Psoriatic Arthritis Drugs Revenue by Company (2020-2022)
3.2.2 Global Psoriatic Arthritis Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Psoriatic Arthritis Drugs Sale Price by Company
3.4 Key Manufacturers Psoriatic Arthritis Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Psoriatic Arthritis Drugs Product Location Distribution
3.4.2 Players Psoriatic Arthritis Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Psoriatic Arthritis Drugs by Geographic Region
4.1 World Historic Psoriatic Arthritis Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Psoriatic Arthritis Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Psoriatic Arthritis Drugs Annual Revenue by Geographic Region
4.2 World Historic Psoriatic Arthritis Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Psoriatic Arthritis Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Psoriatic Arthritis Drugs Annual Revenue by Country/Region
4.3 Americas Psoriatic Arthritis Drugs Sales Growth
4.4 APAC Psoriatic Arthritis Drugs Sales Growth
4.5 Europe Psoriatic Arthritis Drugs Sales Growth
4.6 Middle East & Africa Psoriatic Arthritis Drugs Sales Growth
5 Americas
5.1 Americas Psoriatic Arthritis Drugs Sales by Country
5.1.1 Americas Psoriatic Arthritis Drugs Sales by Country (2017-2022)
5.1.2 Americas Psoriatic Arthritis Drugs Revenue by Country (2017-2022)
5.2 Americas Psoriatic Arthritis Drugs Sales by Type
5.3 Americas Psoriatic Arthritis Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriatic Arthritis Drugs Sales by Region
6.1.1 APAC Psoriatic Arthritis Drugs Sales by Region (2017-2022)
6.1.2 APAC Psoriatic Arthritis Drugs Revenue by Region (2017-2022)
6.2 APAC Psoriatic Arthritis Drugs Sales by Type
6.3 APAC Psoriatic Arthritis Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Psoriatic Arthritis Drugs by Country
7.1.1 Europe Psoriatic Arthritis Drugs Sales by Country (2017-2022)
7.1.2 Europe Psoriatic Arthritis Drugs Revenue by Country (2017-2022)
7.2 Europe Psoriatic Arthritis Drugs Sales by Type
7.3 Europe Psoriatic Arthritis Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Psoriatic Arthritis Drugs by Country
8.1.1 Middle East & Africa Psoriatic Arthritis Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Psoriatic Arthritis Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Psoriatic Arthritis Drugs Sales by Type
8.3 Middle East & Africa Psoriatic Arthritis Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Psoriatic Arthritis Drugs
10.3 Manufacturing Process Analysis of Psoriatic Arthritis Drugs
10.4 Industry Chain Structure of Psoriatic Arthritis Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Psoriatic Arthritis Drugs Distributors
11.3 Psoriatic Arthritis Drugs Customer
12 World Forecast Review for Psoriatic Arthritis Drugs by Geographic Region
12.1 Global Psoriatic Arthritis Drugs Market Size Forecast by Region
12.1.1 Global Psoriatic Arthritis Drugs Forecast by Region (2023-2028)
12.1.2 Global Psoriatic Arthritis Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Psoriatic Arthritis Drugs Forecast by Type
12.7 Global Psoriatic Arthritis Drugs Forecast by Application
13 Key Players Analysis
13.1 Abbvie
13.1.1 Abbvie Company Information
13.1.2 Abbvie Psoriatic Arthritis Drugs Product Offered
13.1.3 Abbvie Psoriatic Arthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbvie Main Business Overview
13.1.5 Abbvie Latest Developments
13.2 Janssen
13.2.1 Janssen Company Information
13.2.2 Janssen Psoriatic Arthritis Drugs Product Offered
13.2.3 Janssen Psoriatic Arthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Janssen Main Business Overview
13.2.5 Janssen Latest Developments
13.3 Amgen
13.3.1 Amgen Company Information
13.3.2 Amgen Psoriatic Arthritis Drugs Product Offered
13.3.3 Amgen Psoriatic Arthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Amgen Main Business Overview
13.3.5 Amgen Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Psoriatic Arthritis Drugs Product Offered
13.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Eli-Lilly
13.5.1 Eli-Lilly Company Information
13.5.2 Eli-Lilly Psoriatic Arthritis Drugs Product Offered
13.5.3 Eli-Lilly Psoriatic Arthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli-Lilly Main Business Overview
13.5.5 Eli-Lilly Latest Developments
13.6 Celgene
13.6.1 Celgene Company Information
13.6.2 Celgene Psoriatic Arthritis Drugs Product Offered
13.6.3 Celgene Psoriatic Arthritis Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Celgene Main Business Overview
13.6.5 Celgene Latest Developments
14 Research Findings and Conclusion
Table 1. Psoriatic Arthritis Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Psoriatic Arthritis Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of TNF Inhibitors
Table 4. Major Players of PDE4 Inhibitors
Table 5. Major Players of Interleukin Blockers
Table 6. Major Players of Other
Table 7. Global Psoriatic Arthritis Drugs Sales by Type (2017-2022) & (K MT)
Table 8. Global Psoriatic Arthritis Drugs Sales Market Share by Type (2017-2022)
Table 9. Global Psoriatic Arthritis Drugs Revenue by Type (2017-2022) & ($ million)
Table 10. Global Psoriatic Arthritis Drugs Revenue Market Share by Type (2017-2022)
Table 11. Global Psoriatic Arthritis Drugs Sale Price by Type (2017-2022) & (USD/MT)
Table 12. Global Psoriatic Arthritis Drugs Sales by Application (2017-2022) & (K MT)
Table 13. Global Psoriatic Arthritis Drugs Sales Market Share by Application (2017-2022)
Table 14. Global Psoriatic Arthritis Drugs Revenue by Application (2017-2022)
Table 15. Global Psoriatic Arthritis Drugs Revenue Market Share by Application (2017-2022)
Table 16. Global Psoriatic Arthritis Drugs Sale Price by Application (2017-2022) & (USD/MT)
Table 17. Global Psoriatic Arthritis Drugs Sales by Company (2020-2022) & (K MT)
Table 18. Global Psoriatic Arthritis Drugs Sales Market Share by Company (2020-2022)
Table 19. Global Psoriatic Arthritis Drugs Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Psoriatic Arthritis Drugs Revenue Market Share by Company (2020-2022)
Table 21. Global Psoriatic Arthritis Drugs Sale Price by Company (2020-2022) & (USD/MT)
Table 22. Key Manufacturers Psoriatic Arthritis Drugs Producing Area Distribution and Sales Area
Table 23. Players Psoriatic Arthritis Drugs Products Offered
Table 24. Psoriatic Arthritis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Psoriatic Arthritis Drugs Sales by Geographic Region (2017-2022) & (K MT)
Table 28. Global Psoriatic Arthritis Drugs Sales Market Share Geographic Region (2017-2022)
Table 29. Global Psoriatic Arthritis Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Psoriatic Arthritis Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Psoriatic Arthritis Drugs Sales by Country/Region (2017-2022) & (K MT)
Table 32. Global Psoriatic Arthritis Drugs Sales Market Share by Country/Region (2017-2022)
Table 33. Global Psoriatic Arthritis Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Psoriatic Arthritis Drugs Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Psoriatic Arthritis Drugs Sales by Country (2017-2022) & (K MT)
Table 36. Americas Psoriatic Arthritis Drugs Sales Market Share by Country (2017-2022)
Table 37. Americas Psoriatic Arthritis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Psoriatic Arthritis Drugs Revenue Market Share by Country (2017-2022)
Table 39. Americas Psoriatic Arthritis Drugs Sales by Type (2017-2022) & (K MT)
Table 40. Americas Psoriatic Arthritis Drugs Sales Market Share by Type (2017-2022)
Table 41. Americas Psoriatic Arthritis Drugs Sales by Application (2017-2022) & (K MT)
Table 42. Americas Psoriatic Arthritis Drugs Sales Market Share by Application (2017-2022)
Table 43. APAC Psoriatic Arthritis Drugs Sales by Region (2017-2022) & (K MT)
Table 44. APAC Psoriatic Arthritis Drugs Sales Market Share by Region (2017-2022)
Table 45. APAC Psoriatic Arthritis Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Psoriatic Arthritis Drugs Revenue Market Share by Region (2017-2022)
Table 47. APAC Psoriatic Arthritis Drugs Sales by Type (2017-2022) & (K MT)
Table 48. APAC Psoriatic Arthritis Drugs Sales Market Share by Type (2017-2022)
Table 49. APAC Psoriatic Arthritis Drugs Sales by Application (2017-2022) & (K MT)
Table 50. APAC Psoriatic Arthritis Drugs Sales Market Share by Application (2017-2022)
Table 51. Europe Psoriatic Arthritis Drugs Sales by Country (2017-2022) & (K MT)
Table 52. Europe Psoriatic Arthritis Drugs Sales Market Share by Country (2017-2022)
Table 53. Europe Psoriatic Arthritis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Psoriatic Arthritis Drugs Revenue Market Share by Country (2017-2022)
Table 55. Europe Psoriatic Arthritis Drugs Sales by Type (2017-2022) & (K MT)
Table 56. Europe Psoriatic Arthritis Drugs Sales Market Share by Type (2017-2022)
Table 57. Europe Psoriatic Arthritis Drugs Sales by Application (2017-2022) & (K MT)
Table 58. Europe Psoriatic Arthritis Drugs Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Psoriatic Arthritis Drugs Sales by Country (2017-2022) & (K MT)
Table 60. Middle East & Africa Psoriatic Arthritis Drugs Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Psoriatic Arthritis Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Psoriatic Arthritis Drugs Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Psoriatic Arthritis Drugs Sales by Type (2017-2022) & (K MT)
Table 64. Middle East & Africa Psoriatic Arthritis Drugs Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Psoriatic Arthritis Drugs Sales by Application (2017-2022) & (K MT)
Table 66. Middle East & Africa Psoriatic Arthritis Drugs Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis Drugs
Table 68. Key Market Challenges & Risks of Psoriatic Arthritis Drugs
Table 69. Key Industry Trends of Psoriatic Arthritis Drugs
Table 70. Psoriatic Arthritis Drugs Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Psoriatic Arthritis Drugs Distributors List
Table 73. Psoriatic Arthritis Drugs Customer List
Table 74. Global Psoriatic Arthritis Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 75. Global Psoriatic Arthritis Drugs Sales Market Forecast by Region
Table 76. Global Psoriatic Arthritis Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Psoriatic Arthritis Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Psoriatic Arthritis Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 79. Americas Psoriatic Arthritis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Psoriatic Arthritis Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 81. APAC Psoriatic Arthritis Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Psoriatic Arthritis Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Europe Psoriatic Arthritis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Psoriatic Arthritis Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Middle East & Africa Psoriatic Arthritis Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Psoriatic Arthritis Drugs Sales Forecast by Type (2023-2028) & (K MT)
Table 87. Global Psoriatic Arthritis Drugs Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Psoriatic Arthritis Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Psoriatic Arthritis Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Psoriatic Arthritis Drugs Sales Forecast by Application (2023-2028) & (K MT)
Table 91. Global Psoriatic Arthritis Drugs Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Psoriatic Arthritis Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Psoriatic Arthritis Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 94. Abbvie Basic Information, Psoriatic Arthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Abbvie Psoriatic Arthritis Drugs Product Offered
Table 96. Abbvie Psoriatic Arthritis Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 97. Abbvie Main Business
Table 98. Abbvie Latest Developments
Table 99. Janssen Basic Information, Psoriatic Arthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Janssen Psoriatic Arthritis Drugs Product Offered
Table 101. Janssen Psoriatic Arthritis Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 102. Janssen Main Business
Table 103. Janssen Latest Developments
Table 104. Amgen Basic Information, Psoriatic Arthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Amgen Psoriatic Arthritis Drugs Product Offered
Table 106. Amgen Psoriatic Arthritis Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 107. Amgen Main Business
Table 108. Amgen Latest Developments
Table 109. Pfizer Basic Information, Psoriatic Arthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Psoriatic Arthritis Drugs Product Offered
Table 111. Pfizer Psoriatic Arthritis Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Eli-Lilly Basic Information, Psoriatic Arthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Eli-Lilly Psoriatic Arthritis Drugs Product Offered
Table 116. Eli-Lilly Psoriatic Arthritis Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 117. Eli-Lilly Main Business
Table 118. Eli-Lilly Latest Developments
Table 119. Celgene Basic Information, Psoriatic Arthritis Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Celgene Psoriatic Arthritis Drugs Product Offered
Table 121. Celgene Psoriatic Arthritis Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 122. Celgene Main Business
Table 123. Celgene Latest Developments
List of Figures
Figure 1. Picture of Psoriatic Arthritis Drugs
Figure 2. Psoriatic Arthritis Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Psoriatic Arthritis Drugs Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Psoriatic Arthritis Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Psoriatic Arthritis Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of TNF Inhibitors
Figure 10. Product Picture of PDE4 Inhibitors
Figure 11. Product Picture of Interleukin Blockers
Figure 12. Product Picture of Other
Figure 13. Global Psoriatic Arthritis Drugs Sales Market Share by Type in 2021
Figure 14. Global Psoriatic Arthritis Drugs Revenue Market Share by Type (2017-2022)
Figure 15. Psoriatic Arthritis Drugs Consumed in Mild Psoriatic Arthritis
Figure 16. Global Psoriatic Arthritis Drugs Market: Mild Psoriatic Arthritis (2017-2022) & (K MT)
Figure 17. Psoriatic Arthritis Drugs Consumed in Moderate Psoriatic Arthritis
Figure 18. Global Psoriatic Arthritis Drugs Market: Moderate Psoriatic Arthritis (2017-2022) & (K MT)
Figure 19. Psoriatic Arthritis Drugs Consumed in Severe Psoriatic Arthritis
Figure 20. Global Psoriatic Arthritis Drugs Market: Severe Psoriatic Arthritis (2017-2022) & (K MT)
Figure 21. Global Psoriatic Arthritis Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global Psoriatic Arthritis Drugs Revenue Market Share by Application in 2021
Figure 23. Psoriatic Arthritis Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Psoriatic Arthritis Drugs Revenue Market Share by Company in 2021
Figure 25. Global Psoriatic Arthritis Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Psoriatic Arthritis Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Psoriatic Arthritis Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Psoriatic Arthritis Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Psoriatic Arthritis Drugs Sales 2017-2022 (K MT)
Figure 30. Americas Psoriatic Arthritis Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Psoriatic Arthritis Drugs Sales 2017-2022 (K MT)
Figure 32. APAC Psoriatic Arthritis Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Psoriatic Arthritis Drugs Sales 2017-2022 (K MT)
Figure 34. Europe Psoriatic Arthritis Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Psoriatic Arthritis Drugs Sales 2017-2022 (K MT)
Figure 36. Middle East & Africa Psoriatic Arthritis Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Psoriatic Arthritis Drugs Sales Market Share by Country in 2021
Figure 38. Americas Psoriatic Arthritis Drugs Revenue Market Share by Country in 2021
Figure 39. United States Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Psoriatic Arthritis Drugs Sales Market Share by Region in 2021
Figure 44. APAC Psoriatic Arthritis Drugs Revenue Market Share by Regions in 2021
Figure 45. China Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Psoriatic Arthritis Drugs Sales Market Share by Country in 2021
Figure 52. Europe Psoriatic Arthritis Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Psoriatic Arthritis Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Psoriatic Arthritis Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Psoriatic Arthritis Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Psoriatic Arthritis Drugs in 2021
Figure 66. Manufacturing Process Analysis of Psoriatic Arthritis Drugs
Figure 67. Industry Chain Structure of Psoriatic Arthritis Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...